|
1
|
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon.
|
Oncotarget
|
2012
|
1.55
|
|
2
|
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells.
|
Ann N Y Acad Sci
|
2004
|
1.09
|
|
3
|
Molecular mechanisms of sorafenib action in liver cancer cells.
|
Cell Cycle
|
2012
|
1.01
|
|
4
|
Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells.
|
Cell Cycle
|
2010
|
0.95
|
|
5
|
Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
|
Cancer Biol Ther
|
2007
|
0.92
|
|
6
|
Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies.
|
Drug Deliv
|
2007
|
0.89
|
|
7
|
The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism.
|
Cancer Lett
|
2012
|
0.89
|
|
8
|
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth.
|
Ann N Y Acad Sci
|
2009
|
0.88
|
|
9
|
Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
|
Mol Pharmacol
|
2009
|
0.86
|
|
10
|
Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells.
|
Exp Mol Med
|
2007
|
0.84
|
|
11
|
Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells.
|
Ann N Y Acad Sci
|
2009
|
0.83
|
|
12
|
Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery.
|
J Drug Target
|
2007
|
0.83
|
|
13
|
COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.
|
OMICS
|
2011
|
0.82
|
|
14
|
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
|
Int J Mol Med
|
2006
|
0.80
|
|
15
|
Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.
|
PLoS One
|
2013
|
0.79
|
|
16
|
Synthesis and characterization of polyaminoacidic polycations for gene delivery.
|
Biomaterials
|
2005
|
0.76
|
|
17
|
Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells.
|
J Nanobiotechnology
|
2014
|
0.75
|